fleroxacin has been researched along with Ischemia in 1 studies
Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Miglioli, PA | 1 |
Kafka, R | 1 |
Bonatti, H | 1 |
Fraedrich, G | 1 |
Allerberger, F | 1 |
Schoeffel, U | 1 |
1 other study available for fleroxacin and Ischemia
Article | Year |
---|---|
Fleroxacin uptake in ischaemic limb tissue.
Topics: Adipose Tissue; Animals; Anti-Infective Agents; Bone and Bones; Diffusion; Extremities; Female; Fler | 2001 |